================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 12, 1999
Derma Sciences, Inc.
(Exact name of registrant as specified in its charter)
Pennsylvania 1-31070 23-2328753
(State or other jurisdiction (Commission (IRS employer
of incorporation) File Number) identification number)
214 Carnegie Center, Suite 100
Princeton, NJ 08540
(609) 514-4744
(Address including zip code and telephone
number, of principal executive offices)
================================================================================
<PAGE>
Item 5. Other Events
On May 12, 1999, the shareholders of Registrant approved an amendment to
Registrant's articles of incorporation to increase the number of authorized
shares of Registrant's common stock from 15,000,000 to 30,000,000. This
amendment became effective on May 26, 1999. For more information relative to
this amendment and for a copy of Registrant's amended and restated articles of
incorporation, please refer to Registrant's definitive proxy statement filed
with the Securities and Exchange Commission on April 13, 1999.
2
<PAGE>
Pursuant to the requirements of the Securities Exchange Act of 1934,
Registrant has caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
DERMA SCIENCES, INC.
Date: May 27, 1999 By:/s/ Stephen T. Wills
--------------------------
Stephen T. Wills, CPA, MST
Vice President and Chief Financial
Officer
3
